The Association of Resistin Levels with Resistance to Insulin in Iraqi Type 2 Diabetes Mellitus Patients

Authors

  • Haider Farhan Salman Department of Clinical Biochemistry, College of Medicine, Kufa University, Najaf, Iraq
  • Majid Kadhum Hussain Department of Clinical Biochemistry, College of Medicine, Kufa University, Najaf, Iraq
  • Hamza J. Mohammed Department of Clinical Biochemistry, College of Medicine, Kufa University, Najaf, Iraq

Keywords:

T2DM, Resistin, BMI, FBS, Insulin, HOMA-1R

Abstract

Resistin, is suggested as an important factor in pathogenesis of insulin resistance associated with obesity, and so might lead to development to T2DM. We want to verify the correlation between resistin and glycaemic parameters and marker of obesity in Iraq T2DM patients. Aims: To test the association of resistin with BMI and insulin resistance in T2DM. Methods: In this study 400 participant’s was included divided in to two groups (200) T2DM patients and (200) healthy control persons. The biochemical and anthropometric parameters included are body mass index (BMI), fasting resistin level, fasting blood  glucose (FBG) ,HOMA-IR and fasting insulin level. Results :  The positively significant correlation between resistin and BMI (r = 0.939, p<0.0001), insulin (r = 0.917, p < 0.0001), FBS(r = 0.966, p<0.0001) and   HOMA-IR (r = 0.947, p<0.0001) in T2DM were noted. Conclusion :    Resistin might be consider as potent link between obesity, insulin resistance and diabetes through disruption the signaling pathway of insulin that may lead to development of insulin resistance and diabetes.

References

-International Diabetic Federation IDF, 2012.Diabetic Atlas.5 th ed (update).

- Shaw, jE., Sicree,R.A,Zimmet,P.Z,2009.Global estimates of the prevalence of diabetics for 2010 and 2030. Diabetes Res .cline. pract.87(1),4-14.et al.,2009)

- Scherer, P.E., 2006. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537–1545.

- Conneely, K.N., et al., 2004. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47, 1782–1788.

- McTernan, P.G., Kusminski, C.M., Kumar, S., 2006. Resistin. Curr. Opin. Lipidol. 17, 170–175.

- Steppan CM, Bailey ST, Bhat S, Brown EJ. Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001;409(6818):307–12.

- Barnes KM, Miner JL. Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci 2009;10(1):96–107.

- Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, et al. SOCS-3inhibits insulin signaling and is upregulated in respose to tumor necrosis factor α in the adipose tissue of obese mice. J Biol Chem2001;276(51):47944–9.

- Chanchay S, Tungtrongchitr R, Hamroongroj T, Phonrat B, Rungseesakorn O, Paksanont S, et al. Plasma resistin, insulin concentration in non diabetic and diabetic, overweight/ obese Thai. Int J Vitam Nutr Res 2006;76(3):125–31.

- Passey R.B., Gillum R.L., Fuller J.B., Urry F.M., Giles, M.L. Evaluation and Comparison of Ten Glucose Methods and the Reference Method Recommended in the Proposed Product Class Standard(1974). Clin. Chem. 1977 Jan; 23, 131-139.

- Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann.Clin. biochem. 1969 Jun 1; 6: 24–25.

- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia.1985; 28 (7): 412–9.

- Gharibeh MY, Al Tawallbeh GM, Abboud MM, Radaideh A, Alhader AA, Khabour OF. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients. Diabetes Metab 2010;36:443–9.

- Chanchay S, Tungtrongchitr R, Hamroongroj T, Phonrat B, Rungseesakorn O, Paksanont S, et al. Plasma resistin, insulin concentration in non diabetic and diabetic, overweight/ obese Thai. Int J Vitam Nutr Res 2006;76(3):125–31.

- Mohammad zadeh G, Zarghami N, Mobaseri M. Serum resistin concentration in obese diabetic patients: Any possible relation to insulin resistin indices? Int J Endocrinol Metab2008;6(4):183–93.

- Sinorita H, Asdie RH, Pramono RB, Purnama LB, Asdie AH. Leptin, Adiponectin and Resistin Concentration in Obesity Class 1 and 2 at Sardjito Hospital Yogyakarta. Acta Med Indones 2010;42(2):74–7.

- Asano H, Izawa H, Nagata K, Nakatochi M, Kobayashi M, Hirashiki A, et al. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia.2010;53(2):795–7.

- Al-Harithy RN, Al- Ghamdi S. Serum resistin, adipocity and insulin resistin in Saudi women with type 2 diabetes mellitus. Ann Saudi Med 2005; 25(4):283–7.

- Al-Harithy RN, Al- Ghamdi S. Serum resistin, adipocity and insulin resistin in Saudi women with type 2 diabetes mellitus. Ann Saudi Med 2005; 25(4):283–7.

- Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, et al. Regulation of Resistin expression and circulating levels in obesity , diabetes and fasting. Diabetes.2004;53(7):1671–9.

- Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008;34(1):2–11.

Downloads

Published

2021-02-26

Issue

Vol. 20 No. 2 (2020)

Section

ARTICLE